Efficacy And Safety In Older Patients (Pts) With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Receiving Cabazitaxel (Cbz) Versus Abiraterone (Abi) Or Enzalutamide (Enz) In The Card Study.Cora N. Sternberg,Daniel Castellano, Johann S. De Bono,Karim Fizazi,Bertrand F. Tombal,Christian Wülfing,Gero Kramer,Jean-Christophe Eymard,Aristotelis Bamias,Joan Carles,Roberto Iacovelli,Bohuslav Melichar,Asgerdur Sverrisdottir,Christine Theodore,Susan Feyerabend,Carole Helissey,Elizabeth Poole,Ayse Ozatilgan,Christine Geffriaud-Ricouard,Ronald De WitJOURNAL OF CLINICAL ONCOLOGY(2020)引用 2|浏览40暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要